Australia Ltd
Pharmaceuticals & Biotechnology
Australia
www.abnamroresearch.com
Analysts
Dr David Stanton
+61 2 8259 5848
[email protected]
Zara Lyons
+61 2 8259 6729
[email protected]
Important disclosures can be found in the Disclosures Appendix.
Priced at close of business 31 January 2008.
ABN AMRO Equities Australia Ltd, ABN 84 002 768 701, AFS Licence 240530
Level 29, ABN AMRO Tower, 88 Phillip Street, Sydney NSW 2000, Australia
Price performance (1M) (3M) (12M)
Price (A$) 0.3 0.5 0.9
Absolute % 2.9 -24.5 -62.6
Rel market % 16.1 -9.3 -61.3
Rel sector % 2.9 -22.5 -61.4
Price
A$0.355
Target price
A$1.15
Market capitalisation
A$105.75m (US$94.00m)
Avg (12mth) daily turnover
A$0.40m (US$0.34m)
Reuters Bloomberg
CUV.AX CUV AU
Synopsis today I am hanging on
- Forums
- ASX - By Stock
- CUV
- abn amro
abn amro
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.09 |
Change
0.100(0.71%) |
Mkt cap ! $705.3M |
Open | High | Low | Value | Volume |
$14.00 | $14.30 | $13.93 | $676.4K | 47.95K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200 | $14.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.16 | 405 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200 | 14.040 |
1 | 150 | 13.920 |
2 | 6000 | 13.900 |
1 | 527 | 13.890 |
2 | 728 | 13.850 |
Price($) | Vol. | No. |
---|---|---|
14.290 | 709 | 1 |
14.300 | 833 | 1 |
14.430 | 668 | 1 |
14.460 | 709 | 1 |
14.490 | 180 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CUV (ASX) Chart |